PERSEUS Primary Analysis Findings in Patients With Newly Diagnosed Multiple Myeloma Who Are Eligible for Stem Cell Transplantation

Brea C. Lipe, MD, discusses the evolving landscape of multiple myeloma treatment, highlighting the current abundance of drugs and the challenges associated with optimizing their use.

Brea C. Lipe, MD describes the unique treatment technology explored in the PERSEUS phase three trial.

Brea C. Lipe, MD explains the trial design and patient population of PERSEUS phase three trial.

Brea C. Lipe, MD highlights key takeaways and patient outcomes from the PERSEUS phase three trial.

Brea C. Lipe, MD explains common grade 3 and grade 4 adverse events observed in the PERSEUS trial.

Brea C. Lipe, MD reflects on how the PERSEUS trial results may affect future treatment approaches.

Brea C. Lipe, MD closes this series highlighting the vast landscape of effective treatments and those on the horizon.